Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily
Introduction
Cellular resistance to anticancer agents is a significant obstacle to the chemotherapeutic treatment of disseminated human cancers. Plasma membrane transporters that function to reduce intracellular drug concentrations represent one class of cellular resistance mechanisms. Pgp, a 170 kD protein that confers resistance to a wide range of natural product anticancer agents, has served as a paradigm for this class of resistance mechanisms [1]. More recently amphipathic anion transporters such as MRP1 and MRP2 (or cMOAT) [2], [3], [4], [5] have been implicated in drug resistance. These two proteins function as primary active transporters of glutathione and glucuronate conjugates as well as several other amphipathic anions [6], [7], [8], [9], [10], [11], [12], [13]. The drug resistance activities of MRP1 and MRP2 overlap with that of Pgp, but are distinguished by their inability to confer resistance to Taxol and by their capacity to confer resistance to some agents that are not part of the Pgp profile [14], [15], [16], [17], [18], [19]. In contrast to Pgp, MRP1 and MRP2 confer resistance to methotrexate and camptothecins, and MRP2 has also been reported to confer resistance to cisplatin [17], [20], [21]. The mechanism by which MRP1 and MRP2 efflux natural product agents differs from that of Pgp in that they are thought to cotransport drugs with glutathione [9], [22], [23], whereas cotransported molecules are not required for drug transport by Pgp.
Analyses of EST sequences and other partial sequences indicate that MRP1 and MRP2 are members of a large subfamily that consists of at least five additional human members [24], [25], [26]. Our laboratory and others have reported the complete coding sequences and expression patterns of four of these five human transporters [27], [28], [29], [30], [31], [32], [33] and two have been described in the rat [34]. Characterizations of some of the more recently described MRP family members indicate that while they also have the capacity to transport amphipathic anions, their substrate selectivities [35], [36], [37], [38], [39] and drug resistance profiles [40], [41], [42], [43], [44], [45] are distinct from those of MRP1 and MRP2.
Of the five ESTs and partial sequences reported to date, the full length coding sequence of only one remains to be described (EST182763) [24]. In searching the data bases we identified a nucleotide sequence that is the product of a cDNA sequencing project and which bears significant similarity to MRP subfamily transporters. In this report the predicted protein encoded by this cDNA, termed MRP7, is analyzed and the expression pattern of its transcript is examined. In so doing we determined that MRP7 is a human MRP subfamily member that corresponds to EST182763. MRP7 transcript is expressed at very low levels in a variety of human tissues examined, encodes a protein of 158 kDa in reticulocyte lysates, and shares the protein topology of MRP1, MRP2, MRP3 and MRP6. Characterization of MRP7 helps to further define the MRP subfamily of transporters.
Section snippets
Computer methods
The Blast program was used to identify data base sequences that are related to EST182763. Protein sequence analyses, including comparisons, alignments and cluster analysies, were performed using the Wisconsin Package version 9.1 (Genetics Computer Group, WI). For the GAP program, the Blosum 62 scoring matrix was used with a gap creation penalty of 8 and a gap extension penalty of 2. These improved parameters differ slightly from those used in our previous analyses of the MRP subfamily [28], [29]
Predicted structure of MRP7
Data base analysis revealed a nucleotide sequence (GenBank accession BAA92227) that shares a high degree of similarity with MRP subfamily transporters. Nucleotides 3131-3633 of this data base submission were identical to EST 182763, the MRP7-related EST for which a complete coding sequence has yet to be described [24]. Analysis of revealed an open reading frame of 4479 nucleotides that was preceded by in frame stop codons at nucleotides 11 and 50. The putative initiation codon was preceded by
Discussion
The analysis we present here indicates that MRP7 is a seventh member of the MRP subfamily. Within this subfamily, the MRP7 domain structure is similar to that of MRP1, MRP2, MRP3, and MRP6, in that it possesses an N-terminal membrane spanning domain [29]. However, pairwise comparisons of amino acid sequences indicate that among the subfamily members MRP7 has the least structural resemblance to MRP1. Nevertheless, its inclusion in this subfamily as determined by cluster analysis and amino acid
Acknowledgements
The work was supported by NIH grant CA73728 to GDK, NIH grant CA 06927 to Fox Chase cancer Center and by an appropriation from the Commonwealth of Pennsylvania.
References (59)
- et al.
cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats
J. Biol. Chem.
(1996) - et al.
The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates
J. Biol. Chem.
(1994) - et al.
ATP-dependent 17 β-estradiol 17-(β-D-glucuronide) transport by multidrug resistance protein (MRP) Inhibition by cholestatic steroids
J. Biol. Chem.
(1996) - et al.
Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver
J. Biol. Chem.
(1998) - et al.
Functional expression of the rat liver canalicular isoform of the multidrug resistance-associated protein
FEBS Lett.
(1997) - et al.
Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2)
FEBS Lett.
(1999) - et al.
Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport
Biochem. Biophys. Res. Commun.
(1998) - et al.
cDNA cloning of a short type of multidrug resistance protein homologue SMRP, from a human lung cancer cell line
Biochem. Biophys. Res. Commun.
(1997) - et al.
cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3)
FEBS Lett.
(1998) - et al.
Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3)
J. Biol. Chem.
(1999)
ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3)
J. Biol. Chem.
The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides
J. Biol. Chem.
pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells
J. Biol. Chem.
Prediction of transmembrane segments in proteins utilizing multiple sequence alignments
J. Mol. Biol.
Membrane topology of the multidrug resistance protein (MRP) A study of glycosylation-site mutants reveals an extracytosolic NH2 terminus
J. Biol. Chem.
Structure and organization of the human alpha class glutathione S-transferase genes and related pseudogenes
Genomics
Mapping of the glutamate-cysteine ligase catalytic subunit gene (GLCLC) to human chromosome 6p12 and mouse chromosome 9D-E and of the regulatory subunit gene (GLCLR) to human chromosome 1p21-p22 and mouse chromosome 3H1-3
Genomics
Clinical features of autosomal dominant congenital nystagmus linked to chromosome 6p12
Am. J. Ophthalmol.
Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome
Hepatology
Biochemistry of multidrug resistance mediated by the multidrug transporter
Annu. Rev. Biochem.
Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
Science
A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation
Cancer Res.
Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene
Science
Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport
Proc. Natl. Acad. Sci. USA
Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump
Cancer Res.
Adenosine triphosphate-dependent transport of anionic conjugates by the rabbit multidrug resistance-associated protein Mrp2 expressed in insect cells
Mol. Pharmacol.
Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA
J. Clin. Invest.
Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution
Cancer Res.
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump
Proc. Natl. Acad. Sci. USA
Cited by (180)
The role of ABCC10/MRP7 in anti-cancer drug resistance and beyond
2024, Drug Resistance UpdatesMultidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance
2021, Drug Resistance UpdatesThe modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
2015, Drug Resistance UpdatesCitation Excerpt :ABCC1 also mediates resistance to TKIs, such as imatinib (Czyzewski and Styczynski, 2009). The human ABCC10 transporter is an ABCC10 encoded gene product localized to chromosome 6p21.1 (Hopper et al., 2001; Kruh et al., 2007). The ABCC10 transporter is a 171-kDa protein containing three membrane-spanning domains (MSD1, MSD2 and MSD3) and two NBDs (Deng et al., 2013; Hopper et al., 2001; Kruh et al., 2007).
- 1
These authors contributed equally.